CeCors (CeCors) Treasury Stock : $0.00 Mil (As of Sep. 2008)

View and export this data going back to 2005. Start your Free Trial

What is CeCors Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. CeCors's treasury stock for the quarter that ended in Sep. 2008 was $0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

CeCors Treasury Stock Historical Data

The historical data trend for CeCors's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeCors Treasury Stock Chart

CeCors Annual Data

Trend

Dec05

Dec06

Dec07

Treasury Stock

CeCors Quarterly Data
	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08
Treasury Stock	Get a 7-Day Free Trial							-	-	-	-	-

CeCors Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

CeCors (CeCors) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeCors Inc (OTCPK:CEOS) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

190 Norseman Street, Suite 100, Etobicoke, ON, CAN, M8Z 2R4

Website

https://www.psykeyworld.com

CeCors Inc is engaged in the acquisition and development of healthcare companies for healthcare supplies and healthcare equipment. The company is engaged in the development of new healthcare technologies and will continue to develop additional markets through healthcare IT and other related entities.